DrugPatentWatch Database Preview
Drugs in Development Information for Tesetaxel
What is the drug development status for Tesetaxel?
Tesetaxel is an investigational drug.
There have been 15 clinical trials for Tesetaxel.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2017.
The most common disease conditions in clinical trials are Breast Neoplasms, Stomach Neoplasms, and Melanoma. The leading clinical trial sponsors are Genta Incorporated, Odonate Therapeutics, Inc., and Odonate Therapeutics, LLC.
There are seven US patents protecting this investigational drug and sixty-nine international patents.
Summary for Tesetaxel
| US Patents | 7 |
| International Patents | 69 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2017-12-01) |
| Vendors | 8 |
Recent Clinical Trials for Tesetaxel
| Title | Sponsor | Phase |
|---|---|---|
| Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Metastatic TNBC and Tesetaxel Monotherapy in Patients With HER2 Negative MBC | Odonate Therapeutics, Inc. | Phase 2 |
| Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC | Odonate Therapeutics, Inc. | Phase 2 |
| Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, MBC (CONTESSA) | Odonate Therapeutics, LLC | Phase 3 |
Clinical Trial Summary for Tesetaxel
Top disease conditions for Tesetaxel
Top clinical trial sponsors for Tesetaxel
US Patents for Tesetaxel
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tesetaxel | Start Trial | Method for producing 2-azetidinone derivative | Daiichi Pharmaceutical Co., Ltd. (Tokyo, JP) | Start Trial |
| Tesetaxel | Start Trial | Crystals of taxane derivative and process for their production | Daiichi Pharmaceutical Co., Ltd. (Tokyo, JP) | Start Trial |
| Tesetaxel | Start Trial | Method for producing pentacyclic taxans | Daiichi Pharmaceutical Co., Ltd. (Tokyo, JP) | Start Trial |
| Tesetaxel | Start Trial | Method for producing pentacyclic taxans | Daiichi Pharmaceutical Co., Ltd. (Tokyo, JP) | Start Trial |
| Tesetaxel | Start Trial | Taxane compounds, compositions and methods | GFV, LLC (San Diego, CA) | Start Trial |
| Tesetaxel | Start Trial | Taxane compounds, compositions and methods | GFV, LLC (San Diego, CA) | Start Trial |
| Tesetaxel | Start Trial | Taxane compounds, compositions and methods | GFV, LLC (San Diego, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tesetaxel
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tesetaxel | Austria | 407130 | 2021-03-07 | Start Trial |
| Tesetaxel | China | 1266148 | 2021-03-07 | Start Trial |
| Tesetaxel | China | 1507443 | 2021-03-07 | Start Trial |
| Tesetaxel | Germany | 50212728 | 2021-03-07 | Start Trial |
| Tesetaxel | European Patent Office | 1375495 | 2021-03-07 | Start Trial |
| Tesetaxel | Spain | 2311591 | 2021-03-07 | Start Trial |
| Tesetaxel | Hong Kong | 1058668 | 2021-03-07 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
